MS
ALXN

Maven Securities’s Alexion Pharmaceuticals ALXN Stock Holding History

Maven Securities’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-62,000
Closed -$11.4M – 1640
2021
Q2 		$11.4M Sell
62,000
-87,329
-58% -$15M 1.2% 32
2021
Q1 		$23M Buy
149,329
+47,919
+47% +$7.41M 2.15% 11
2020
Q4 		$15.8M Buy
+101,410
New +$13M 1.63% 4
2020
Q3 		– Hold
0
– – – 910
2020
Q2 		– Hold
0
– – – 679
2017
Q1 		– Sell
-177
Closed -$22K – 67
2016
Q4 		$22K Buy
+177
New +$21.7K 0.02% 40

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return